Presentation TCT 2022 LVOT Obstruction: Prediction Models and Emerging Prevention Techniques Presenter: Mayra Guerrero September 18, 2022
Presentation TCT 2022 Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve Presenter: Vinayak N. Bapat September 18, 2022
Presentation Interventional Complications 2022 LVOT obstruction post TMVR Presenter: Adam Greenbaum July 15, 2022
Presentation TVT 2022 LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management Presenter: Vinayak N. Bapat June 10, 2022
Presentation TVT 2022 Mitral Transcatheter Edge-to-Edge Repair for Dynamic LVOT Obstruction Presenter: Tim Hinohara June 10, 2022
Presentation TVT 2022 #2 Case Resolution: Acute LVOT Obstruction Post-TMVR Presenter: Adam Greenbaum June 08, 2022
Presentation TVT 2022 #2 Case Presentation: Acute LVOT Obstruction Post-TMVR Presenter: Adam Greenbaum June 08, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022
News Conference News ACC 2022 Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM Yael L. Maxwell April 02, 2022
News Conference News STS 2022 CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices Todd Neale February 03, 2022
News Conference News PCR London Valves 2021 ‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI Michael O'Riordan November 25, 2021
Presentation TVT 2021 Killing Two Birds With One Stone; Reducing LVOT Obstruction While Tackling Your Mitral Regurgitation Presenter: Elliott Elias July 21, 2021
Presentation TVT 2021 Case Resolution: LVOT Obstruction After Mitral ViMAC Presenter: Mayra Guerrero July 20, 2021
Presentation TVT 2021 Case Introduction: LVOT Obstruction After Mitral ViMAC Presenter: Mayra Guerrero July 20, 2021
News Conference News ESC 2020 EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class Michael O'Riordan August 29, 2020
News Daily News Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats Todd Neale July 31, 2020
News Daily News Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Shelley Wood May 11, 2020
News Daily News Early Signs Positive for Tendyne TMVR in Severe MAC Caitlin E. Cox September 11, 2019
News Daily News Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR Yael L. Maxwell July 11, 2019